How do you sequence ADT relative to the start of RT?

Happy New Year to the MedNet! This is a great question that should remind us to question everything.

This is an important question that the prostate community I have felt since I was in training has over simplified for decades.

First: Our current nomenclature has problems. Most residents and facult...

Yes, this was an interesting study by Malone et al., which I enjoyed reading. Given the lack of significant advantage to either approach on the study, we continue to typically give 2 months of neoadjuvant ADT.

As opposed to the 3DCRT approach on the study, we use VMAT with fairly tight margins (3-4...